A new way to detect the SARS-CoV-2 Alpha variant in wastewater
SMART researchers have developed an innovative method to detect and quantify the B.1.1.7 (Alpha) variant of concern via wastewater epidemiology.
SMART researchers have developed an innovative method to detect and quantify the B.1.1.7 (Alpha) variant of concern via wastewater epidemiology.
Four times faster than conventional PCR methods, new RADICA approach is highly specific, sensitive, and resistant to inhibitors.
Graduate student Ellen Zhong helped biologists and mathematicians reach across departmental lines to address a longstanding problem in electron microscopy.
The sensor technology could also be used to create clothing that detects a variety of pathogens and other threats.
Professor Markus Buehler composed it, and a South Korean orchestra performed it; it’s the latest in a series of artistic collaborations sparked by Buehler’s exploration of the structure of SARS-CoV-2.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
Research on how water behaves in a proton channel provides possible new avenues for flu treatment.
Researchers develop a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients.
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Study suggests mechanical properties of spike proteins can predict infectivity and lethality of different coronaviruses.
Letting an algorithm decide which maintenance holes to test for evidence of coronavirus could improve pandemic containment efforts.
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.